IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients June 9, 2021 Read More »
IGC Completes Cohort 1 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients May 14, 2021 Read More »
IGC Receives Another Patent for a Cannabinoid-Based Cream for Treating Pain March 8, 2021 Read More »
IGC Reports Financial Results for September 30, 2020 Quarter and Start of Phase 1 Cannabinoid Clinical Trial for Alzheimer’s Patients November 23, 2020 Read More »
IGC Commences Phase 1 of Cannabinoid Clinical Trial for Alzheimer’s Patients November 23, 2020 Read More »
